APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sugammadex

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sugammadex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchSugammadex Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Sugammadex Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Sugammadex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sugammadex Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Sugammadex Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sugammadex market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sugammadex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sugammadex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sugammadex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sugammadex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sugammadex include Renfu Pharma, Yangzi River Pharma, Teva, Sandoz, Merck & Co, Kelun Pharma, Viatris, STADA Arzneimittel and Intas Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sugammadex market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sugammadex and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sugammadex sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sugammadex market size, projected growth trends, production technologies, key applications, and end-use industries.

Sugammadex Segment by Company

Renfu Pharma

Yangzi River Pharma

Teva

Sandoz

Merck & Co

Kelun Pharma

Viatris

STADA Arzneimittel

Intas Pharmaceuticals

Hikma Pharmaceuticals

Fresenius

Dr Reddy's Laboratories

Cipla

Aspen Group

Sugammadex Segment by Type

Vials

Ampoules

Sugammadex Segment by Application

Hospital

Mobile Surgery Centre

Sugammadex Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sugammadex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sugammadex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sugammadex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sugammadex market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sugammadex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sugammadex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sugammadex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sugammadex Industry Trends Table 2. Sugammadex Industry Drivers Table 3. Sugammadex Industry Opportunities and Challenges Table 4. Sugammadex Industry Restraints Table 5. Global Sugammadex Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sugammadex Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sugammadex Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Sugammadex Sales Market Share by Manufacturers Table 9. Global Sugammadex Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Sugammadex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sugammadex Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sugammadex Manufacturers, Product Type & Application Table 13. Global Sugammadex Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sugammadex by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vials Table 17. Major Manufacturers of Ampoules Table 18. Global Sugammadex Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Sugammadex Sales by Type (2021-2026) & (k units) Table 20. Global Sugammadex Sales by Type (2027-2032) & (k units) Table 21. Global Sugammadex Sales Market Share by Type (2021-2026) Table 22. Global Sugammadex Sales Market Share by Type (2027-2032) Table 23. Global Sugammadex Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Sugammadex Revenue by Type (2021-2026) & (k units) Table 25. Global Sugammadex Revenue by Type (2027-2032) & (k units) Table 26. Global Sugammadex Revenue Market Share by Type (2021-2026) Table 27. Global Sugammadex Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Mobile Surgery Centre Table 30. Global Sugammadex Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Sugammadex Sales by Application (2021-2026) & (k units) Table 32. Global Sugammadex Sales by Application (2027-2032) & (k units) Table 33. Global Sugammadex Sales Market Share by Application (2021-2026) Table 34. Global Sugammadex Sales Market Share by Application (2027-2032) Table 35. Global Sugammadex Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Sugammadex Revenue by Application (2021-2026) & (k units) Table 37. Global Sugammadex Revenue by Application (2027-2032) & (k units) Table 38. Global Sugammadex Revenue Market Share by Application (2021-2026) Table 39. Global Sugammadex Revenue Market Share by Application (2027-2032) Table 40. Global Sugammadex Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Sugammadex Sales by Region (2021-2026) & (k units) Table 42. Global Sugammadex Sales Market Share by Region (2021-2026) Table 43. Global Sugammadex Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Sugammadex Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Sugammadex Sales by Country (2021-2026) & (k units) Table 47. North America Sugammadex Sales by Country (2027-2032) & (k units) Table 48. Europe Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Sugammadex Sales by Country (2021-2026) & (k units) Table 50. Europe Sugammadex Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Sugammadex Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Sugammadex Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Sugammadex Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Sugammadex Sales by Country (2027-2032) & (k units) Table 57. Global Sugammadex Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sugammadex Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Sugammadex Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Sugammadex Revenue Market Share by Region (2021-2026) Table 61. Global Sugammadex Revenue Market Share by Region (2027-2032) Table 62. Renfu Pharma Company Information Table 63. Renfu Pharma Business Overview Table 64. Renfu Pharma Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Renfu Pharma Sugammadex Product Portfolio Table 66. Renfu Pharma Recent Development Table 67. Yangzi River Pharma Company Information Table 68. Yangzi River Pharma Business Overview Table 69. Yangzi River Pharma Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Yangzi River Pharma Sugammadex Product Portfolio Table 71. Yangzi River Pharma Recent Development Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Teva Sugammadex Product Portfolio Table 76. Teva Recent Development Table 77. Sandoz Company Information Table 78. Sandoz Business Overview Table 79. Sandoz Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sandoz Sugammadex Product Portfolio Table 81. Sandoz Recent Development Table 82. Merck & Co Company Information Table 83. Merck & Co Business Overview Table 84. Merck & Co Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck & Co Sugammadex Product Portfolio Table 86. Merck & Co Recent Development Table 87. Kelun Pharma Company Information Table 88. Kelun Pharma Business Overview Table 89. Kelun Pharma Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Kelun Pharma Sugammadex Product Portfolio Table 91. Kelun Pharma Recent Development Table 92. Viatris Company Information Table 93. Viatris Business Overview Table 94. Viatris Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Viatris Sugammadex Product Portfolio Table 96. Viatris Recent Development Table 97. STADA Arzneimittel Company Information Table 98. STADA Arzneimittel Business Overview Table 99. STADA Arzneimittel Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. STADA Arzneimittel Sugammadex Product Portfolio Table 101. STADA Arzneimittel Recent Development Table 102. Intas Pharmaceuticals Company Information Table 103. Intas Pharmaceuticals Business Overview Table 104. Intas Pharmaceuticals Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Intas Pharmaceuticals Sugammadex Product Portfolio Table 106. Intas Pharmaceuticals Recent Development Table 107. Hikma Pharmaceuticals Company Information Table 108. Hikma Pharmaceuticals Business Overview Table 109. Hikma Pharmaceuticals Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Hikma Pharmaceuticals Sugammadex Product Portfolio Table 111. Hikma Pharmaceuticals Recent Development Table 112. Fresenius Company Information Table 113. Fresenius Business Overview Table 114. Fresenius Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Fresenius Sugammadex Product Portfolio Table 116. Fresenius Recent Development Table 117. Dr Reddy's Laboratories Company Information Table 118. Dr Reddy's Laboratories Business Overview Table 119. Dr Reddy's Laboratories Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Dr Reddy's Laboratories Sugammadex Product Portfolio Table 121. Dr Reddy's Laboratories Recent Development Table 122. Cipla Company Information Table 123. Cipla Business Overview Table 124. Cipla Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Cipla Sugammadex Product Portfolio Table 126. Cipla Recent Development Table 127. Aspen Group Company Information Table 128. Aspen Group Business Overview Table 129. Aspen Group Sugammadex Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Aspen Group Sugammadex Product Portfolio Table 131. Aspen Group Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Sugammadex Distributors List Table 135. Sugammadex Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Sugammadex Product Image Figure 2. Global Sugammadex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sugammadex Market Size (2021-2032) & (US$ Million) Figure 4. Global Sugammadex Sales (2021-2032) & (k units) Figure 5. Global Sugammadex Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sugammadex Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vials Image Figure 9. Ampoules Image Figure 10. Global Sugammadex Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Sugammadex Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Sugammadex Sales Market Share by Type (2021-2032) Figure 13. Global Sugammadex Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Sugammadex Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sugammadex Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Mobile Surgery Centre Image Figure 18. Global Sugammadex Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Sugammadex Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Sugammadex Sales Market Share by Application (2021-2032) Figure 21. Global Sugammadex Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Sugammadex Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Sugammadex Revenue Market Share by Application (2021-2032) Figure 24. North America Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Sugammadex Sales Market Share by Country (2021-2032) Figure 26. U.S. Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Sugammadex Sales Market Share by Country (2021-2032) Figure 31. Germany Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Sugammadex Sales Market Share by Country (2021-2032) Figure 38. China Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Sugammadex Sales Market Share by Country (2021-2032) Figure 46. Brazil Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Sugammadex Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Sugammadex Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Sugammadex Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Sugammadex Revenue (2021-2032) & (US$ Million) Figure 57. North America Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Sugammadex Revenue (2021-2032) & (US$ Million) Figure 59. Europe Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Sugammadex Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Sugammadex Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Sugammadex Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Sugammadex Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Vials
  • Ampoules
Applications
  • Hospital
  • Mobile Surgery Centre
Companies covered
  • Renfu Pharma
  • Yangzi River Pharma
  • Teva
  • Sandoz
  • Merck & Co
  • Kelun Pharma
  • Viatris
  • STADA Arzneimittel
  • Intas Pharmaceuticals
  • Hikma Pharmaceuticals
  • Fresenius
  • Dr Reddy's Laboratories
  • Cipla
  • Aspen Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sugammadex Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sugammadex Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sugammadex Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sugammadex Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sugammadex Market Dynamics
  1. 2.1 Sugammadex Industry Trends
  2. 2.2 Sugammadex Industry Drivers
  3. 2.3 Sugammadex Industry Opportunities and Challenges
  4. 2.4 Sugammadex Industry Restraints
3 Sugammadex Market by Manufacturers
  1. 3.1 Global Sugammadex Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sugammadex Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sugammadex Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sugammadex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sugammadex Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sugammadex Manufacturers, Product Type & Application
  7. 3.7 Global Sugammadex Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sugammadex Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sugammadex Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sugammadex Tier 1, Tier 2, and Tier 3
4 Sugammadex Market by Type
  1. 4.1 Sugammadex Type Introduction
  2. 4.1.1 Vials
  3. 4.1.2 Ampoules
  4. 4.2 Global Sugammadex Sales by Type
  5. 4.2.1 Global Sugammadex Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sugammadex Sales by Type (2021-2032)
  7. 4.2.3 Global Sugammadex Sales Market Share by Type (2021-2032)
  8. 4.3 Global Sugammadex Revenue by Type
  9. 4.3.1 Global Sugammadex Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sugammadex Revenue by Type (2021-2032)
  11. 4.3.3 Global Sugammadex Revenue Market Share by Type (2021-2032)
5 Sugammadex Market by Application
  1. 5.1 Sugammadex Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Mobile Surgery Centre
  4. 5.2 Global Sugammadex Sales by Application
  5. 5.2.1 Global Sugammadex Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sugammadex Sales by Application (2021-2032)
  7. 5.2.3 Global Sugammadex Sales Market Share by Application (2021-2032)
  8. 5.3 Global Sugammadex Revenue by Application
  9. 5.3.1 Global Sugammadex Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sugammadex Revenue by Application (2021-2032)
  11. 5.3.3 Global Sugammadex Revenue Market Share by Application (2021-2032)
6 Global Sugammadex Sales by Region
  1. 6.1 Global Sugammadex Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sugammadex Sales by Region (2021-2032)
  3. 6.2.1 Global Sugammadex Sales by Region (2021-2026)
  4. 6.2.2 Global Sugammadex Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sugammadex Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sugammadex Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sugammadex Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sugammadex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sugammadex Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sugammadex Revenue by Region
  1. 7.1 Global Sugammadex Revenue by Region
  2. 7.1.1 Global Sugammadex Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sugammadex Revenue by Region (2021-2026)
  4. 7.1.3 Global Sugammadex Revenue by Region (2027-2032)
  5. 7.1.4 Global Sugammadex Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sugammadex Revenue (2021-2032)
  8. 7.2.2 North America Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sugammadex Revenue (2021-2032)
  11. 7.3.2 Europe Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sugammadex Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sugammadex Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sugammadex Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Renfu Pharma
  2. 8.1.1 Renfu Pharma Company Information
  3. 8.1.2 Renfu Pharma Business Overview
  4. 8.1.3 Renfu Pharma Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Renfu Pharma Sugammadex Product Portfolio
  6. 8.1.5 Renfu Pharma Recent Developments
  7. 8.2 Yangzi River Pharma
  8. 8.2.1 Yangzi River Pharma Company Information
  9. 8.2.2 Yangzi River Pharma Business Overview
  10. 8.2.3 Yangzi River Pharma Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangzi River Pharma Sugammadex Product Portfolio
  12. 8.2.5 Yangzi River Pharma Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Sugammadex Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Sugammadex Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Merck & Co
  26. 8.5.1 Merck & Co Company Information
  27. 8.5.2 Merck & Co Business Overview
  28. 8.5.3 Merck & Co Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck & Co Sugammadex Product Portfolio
  30. 8.5.5 Merck & Co Recent Developments
  31. 8.6 Kelun Pharma
  32. 8.6.1 Kelun Pharma Company Information
  33. 8.6.2 Kelun Pharma Business Overview
  34. 8.6.3 Kelun Pharma Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kelun Pharma Sugammadex Product Portfolio
  36. 8.6.5 Kelun Pharma Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Sugammadex Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 STADA Arzneimittel
  44. 8.8.1 STADA Arzneimittel Company Information
  45. 8.8.2 STADA Arzneimittel Business Overview
  46. 8.8.3 STADA Arzneimittel Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 STADA Arzneimittel Sugammadex Product Portfolio
  48. 8.8.5 STADA Arzneimittel Recent Developments
  49. 8.9 Intas Pharmaceuticals
  50. 8.9.1 Intas Pharmaceuticals Company Information
  51. 8.9.2 Intas Pharmaceuticals Business Overview
  52. 8.9.3 Intas Pharmaceuticals Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intas Pharmaceuticals Sugammadex Product Portfolio
  54. 8.9.5 Intas Pharmaceuticals Recent Developments
  55. 8.10 Hikma Pharmaceuticals
  56. 8.10.1 Hikma Pharmaceuticals Company Information
  57. 8.10.2 Hikma Pharmaceuticals Business Overview
  58. 8.10.3 Hikma Pharmaceuticals Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Pharmaceuticals Sugammadex Product Portfolio
  60. 8.10.5 Hikma Pharmaceuticals Recent Developments
  61. 8.11 Fresenius
  62. 8.11.1 Fresenius Company Information
  63. 8.11.2 Fresenius Business Overview
  64. 8.11.3 Fresenius Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius Sugammadex Product Portfolio
  66. 8.11.5 Fresenius Recent Developments
  67. 8.12 Dr Reddy's Laboratories
  68. 8.12.1 Dr Reddy's Laboratories Company Information
  69. 8.12.2 Dr Reddy's Laboratories Business Overview
  70. 8.12.3 Dr Reddy's Laboratories Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr Reddy's Laboratories Sugammadex Product Portfolio
  72. 8.12.5 Dr Reddy's Laboratories Recent Developments
  73. 8.13 Cipla
  74. 8.13.1 Cipla Company Information
  75. 8.13.2 Cipla Business Overview
  76. 8.13.3 Cipla Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cipla Sugammadex Product Portfolio
  78. 8.13.5 Cipla Recent Developments
  79. 8.14 Aspen Group
  80. 8.14.1 Aspen Group Company Information
  81. 8.14.2 Aspen Group Business Overview
  82. 8.14.3 Aspen Group Sugammadex Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aspen Group Sugammadex Product Portfolio
  84. 8.14.5 Aspen Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sugammadex Value Chain Analysis
  2. 9.1.1 Sugammadex Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sugammadex Production Mode & Process
  6. 9.2 Sugammadex Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sugammadex Distributors
  9. 9.2.3 Sugammadex Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst